Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Process for the preparation of 1-amino-3,5-dimethyladamantane hydrochloride

A technology of dimethyladamantane and dimethyladamantine, applied in the field of preparation of 1-amino-3,5-dimethyladamantane hydrochloride, which can solve problems such as danger

Inactive Publication Date: 2008-01-09
TEVA PHARMA FINE CHEMI
View PDF7 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

And as mentioned above, the hazardous reactants lithium and chloramine are required in the electrophilic amination reaction

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Process for the preparation of 1-amino-3,5-dimethyladamantane hydrochloride
  • Process for the preparation of 1-amino-3,5-dimethyladamantane hydrochloride
  • Process for the preparation of 1-amino-3,5-dimethyladamantane hydrochloride

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1-1

[0068] Example 1-Synthesis of 1-Acetylamino-3,5-Dimethyladamantane

[0069] The following examples are used to illustrate the embodiments of the present invention.

[0070] The first step in the synthesis of 1-acetylamino-3,5-dimethyladamantane follows the following synthesis scheme.

[0071]

[0072] At room temperature, 500 g (2.056 moles) of 1-bromo-3,5-dimethyladamantane and 500 ml of 393 g (9.6 moles) of acetonitrile are introduced into a three-necked round bottom equipped with a thermometer, a condenser and a mechanical stirrer In the flask. Then, 806 grams of 75% phosphoric acid (6.2 moles) was added dropwise in about 15 minutes, keeping the temperature below 40°C. The resulting two-phase mixture was heated to 87±2°C and kept at this temperature for 3 hours.

[0073] 1000 ml of n-butanol and 770 ml of water are added to produce a homogeneous solution. Sodium hydroxide 30% (337.5 grams) was added to create a two-phase system. The phases were separated, and 350 ml of wate...

Embodiment 3

[0075] Example 3-Synthesis of memantine free base from n-acetyl-memantine

[0076] At room temperature, 10 g (0.045 mol) of n-acetyl-memantine, 75 ml of n-butanol and 10.5 g of sodium hydroxide flakes (0.263 mol) were introduced into a three-necked round bottom flask equipped with a thermometer, condenser and mechanical stirrer in. The resulting suspension was heated to 120°C and kept at 120°C for 10 hours. The reaction mixture was cooled to 80°C, and 25 ml of water was added. Separate the phases, add 25 ml of water to the rich organic phase, and adjust the pH to 10.5-11 with 37% hydrochloric acid. After stirring, the phases are separated, and 25 ml of water is added to the rich organic phase. After stirring, the phases were separated again. The resulting organic phase of butanol was concentrated in vacuo at an internal temperature of 70°C until an oily residue (10.5 g) was obtained to obtain memantine free base.

[0077] (Optionally add 100 ml of ethyl acetate to the oily resid...

Embodiment 4

[0079] Example 4-Synthesis of Memantine Hydrochloride from n-Acetyl Memantine

[0080] According to the following synthesis scheme, steps 2 and 3 of synthesizing 1-amino-3,5-dimethyladamantane synthesize memantine hydrochloride.

[0081]

[0082] At room temperature, 50 g (0.2259 mol) of n-acetyl-memantine, 200 ml of n-butanol, and 80.29 g of 89.9% potassium hydroxide flakes (1.288 mol) were introduced into the three-neck equipped with thermometer, condenser and mechanical stirrer Round bottom flask. The resulting suspension was heated to 130±2°C and kept at 130±2°C for 10-11 hours. The reaction mixture was cooled to 50°C, and 150 ml of water was added. Separate the phases, add 75 ml of water to the rich organic phase, and adjust the pH to 10.5-11 with 37% hydrochloric acid. After stirring, separate the phases and add 75 ml of water to the organic rich phase. After stirring, the phases were separated again.

[0083] The resulting solution was filtered, and 23.1 g of 37% hydroc...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A crystalline Form II of memantine hydrochloride, pharmaceutical compositions containing crystalline Form II, and methods of preparing crystalline Forms I and II of memantine hydrochloride are provided.

Description

[0001] Related application [0002] This application claims the rights and interests of U.S. Provisional Patent Application 60 / 642,957 filed on January 11, 2005 and U.S. Provisional Patent Application 60 / 677,599 filed on May 3, 2005, the contents of which are incorporated herein by reference. Invention field [0003] The present invention relates to a method for preparing 1-amino-3,5-dimethyladamantane hydrochloride ("Memantine hydrochloride") and its intermediates. Background of the invention [0004] Memantine hydrochloride is one of the group of drugs called tricyclic antiviral drugs (TAVs) and provides good and long-lasting activation of N-methyl-D-aspartate (NMDA) receptors in the central nervous system. Therefore, it can be used to treat Parkinson's disease and Alzheimer's disease. The chemical structure of memantine hydrochloride is shown below: [0005] [0006] Three methods for synthesizing memantine hydrochloride are disclosed in the prior art: [0007] A) Hydrolysi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07C231/06C07C233/06C07C209/50C07C211/38
Inventor V·默利S·曼托瓦尼P·达维里奥S·比安基A·斯普里费科
Owner TEVA PHARMA FINE CHEMI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products